Quantcast

Latest diabetic neuropathy Stories

2011-08-19 00:02:04

Nutri-Med Logic Corp says that studies done by University Hospital of Düsseldorf, Germany, relating to the role of anti-oxidant nutrient "R-Alpha Lipoic" in Diabetics, resulted in a meaningful improvement and was well tolerated. The study found that changes were significantly better for the Alpha Lipoic Group. Miami, Florida (PRWEB) August 18, 2011 Nutri-Med Logic Corp: A recent study published in Diabetes Care (2011 July 25), highlighted the importance of R-Alpha Lipoic for the diets...

2011-06-24 17:23:14

Results may provide new strategy to prevent amputations Blood vessels and supporting cells appear to be pivotal partners in repairing nerves ravaged by diabetic neuropathy, and nurturing their partnership with nerve cells might make the difference between success and failure in experimental efforts to regrow damaged nerves, Johns Hopkins researchers report in a new study. About 20 percent of diabetics experience neuropathy, a painful tingling, burning or numbness in the hands and feet that...

2011-06-24 16:00:00

LA JOLLA, Calif., June 24, 2011 /PRNewswire/ -- Cebix Incorporated announced today that preclinical data for its long-acting form of C-peptide, Ersatta(TM) (CBX129801), demonstrated a half-life of three days as compared to one hour for native C-peptide. Ersatta halted the impairment in nerve conduction velocity, a measure of the rate at which electrical signals travel through the nerves, in an animal model of diabetic peripheral neuropathy. Additionally, clinical data showed that native...

2011-06-24 07:52:50

(Ivanhoe Newswire)--Feelings of painful tingling, burning, and numbness in the hands and feet can be reflective of major nerve damage. About twenty percent of diabetics experience these symptoms, know as neuropathy, which can sometimes lead to infections and amputations of the toes, fingers, hands, and feet. However, in a recent study conducted at Johns Hopkins, blood vessels and supporting cells appeared to be pivotal partners in repairing nerves damaged by diabetic neuropathy. Current...

2011-06-23 19:58:23

Valley Presbyterian specialist co-authors case study to highlight the danger of pets in the presence of open wounds In a case study that illustrates the need for people with diabetes to be cautious of foot injuries and to protect themselves from pets, a woman with numbness in her feet caused by diabetic neuropathy slept through a traumatic episode in which her Jack Russell terrier chewed off part of her slightly infected big toe, according to an article published in this month's issue of the...

2011-06-16 07:00:00

LA JOLLA, Calif., June 16, 2011 /PRNewswire/ -- Cebix Incorporated announced today it is advancing the development of modified C-peptide for the treatment of complications of diabetes. The biopharmaceutical company has initiated a Phase 1b clinical trial to evaluate Ersatta(TM), its proprietary long-acting form of C-peptide, in patients with type 1 diabetes who, because of their disease, lack this endogenous peptide. Following the successful completion of this study, the company is...

2011-06-14 08:11:00

BALTIMORE, June 14, 2011 /PRNewswire/ -- Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that data from the Phase 2b trial of ARC-4558 for the treatment of pain associated with painful diabetic neuropathy (PDN) will be the subject of two poster presentations at upcoming medical meetings. The first poster will be presented at the American Diabetes Association's 71st Scientific Sessions, June 24-28,...

2011-05-16 07:10:00

NEW YORK, May 16, 2011 /PRNewswire/ -- For National Neuropathy Week, May 16-20, The Neuropathy Association is launching a "Talk Neuropathy" campaign featuring patient-guided interviews with Association spokesperson and former star of screen and stage Rev. Mother Dolores Hart, O.S.B., Emmy-Award winning journalist Pia Lindstrom, and critically acclaimed author and poet Sarah Manguso. Using questions submitted by neuropathy patients for these high-profile advocates, the "Talk Neuropathy"...

2011-04-26 15:02:00

RICHMOND, Calif., April 26, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported first quarter 2011 financial results and accomplishments. For the first quarter ended March 31, 2011, Sangamo reported a consolidated net loss of $9.6 million, or $0.21 per share, compared to a net loss of $4.0 million, or $0.09 per share, for the same period in 2010. As of March 31, 2011, the company had cash, cash equivalents and marketable securities of $49.2 million. Revenues...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'